Back
Ligand Pharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
LGND
Ligand Pharmaceuticals, Inc.
Last Price:
$200.02
Seasonality Move:
4.34%
7 Day Trial
ALL ACCESS PASS
$
7
Ligand Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Ligand Pharmaceuticals, Inc. has on average historically risen by 25% based on the past 31 years of stock performance.
-
Ligand Pharmaceuticals, Inc. has risen higher in 16 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 51.61%
-
Is Ligand Pharmaceuticals, Inc. Stock Undervalued?The current Ligand Pharmaceuticals, Inc. [LGND] share price is $199.93. The Score for LGND is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
LGND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Ligand Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Ligand Pharmaceuticals, Inc. has on average historically risen by 25% based on the past 31 years of stock performance.
Ligand Pharmaceuticals, Inc. Stock Rating
Sell
47
Ligand Pharmaceuticals, Inc. (LGND)
is a Sell
Is Ligand Pharmaceuticals, Inc. overpriced?
-
Ligand Pharmaceuticals, Inc. has risen higher in 16 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 51.61%
Ligand Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
ligand.com
52-Week Data
52-Week High:
227.92
52-Week Low:
93.58
Prediction Charts
Market Cap:
4B
Price in USD:
199.93
Volume:
221.9K
Beta:
1.44
Technical Analysis
SMA50:
198.10
SMA100:
197.55
SMA200:
176.56
52-Wk Change:
83.88%
Stock Predictions
-
Is Ligand Pharmaceuticals, Inc. stock public?Yes, Ligand Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Ligand Pharmaceuticals, Inc. stock quote today?The Ligand Pharmaceuticals, Inc. stock price is 199.93 USD today.
-
How to buy Ligand Pharmaceuticals, Inc. stock online?You can buy Ligand Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 204.30 | 207.80 | 210.42 | 204.30 |
| Mar-17 | 208.00 | 210.99 | 213.31 | 205.47 |
| Mar-18 | 209.83 | 209.52 | 213.21 | 201.94 |
| Mar-19 | 207.44 | 210.49 | 214.45 | 206.92 |
| Mar-20 | 213.20 | 204.81 | 214.27 | 204.02 |
| Mar-23 | 208.33 | 199.81 | 214.29 | 199.74 |
| Mar-24 | 200.88 | 201.65 | 202.07 | 195.45 |
| Mar-25 | 203.17 | 204.56 | 208.89 | 201.28 |
| Mar-26 | 204.99 | 203.95 | 207.89 | 202.30 |
| Mar-27 | 202.17 | 195.48 | 205.87 | 194.44 |
| Mar-30 | 195.65 | 192.50 | 197.83 | 188.67 |
| Mar-31 | 195.98 | 199.33 | 201.96 | 192.96 |
| Apr-1 | 203.50 | 199.69 | 205.50 | 198.01 |
| Apr-2 | 197.54 | 199.93 | 201.42 | 196.10 |
Ligand Pharmaceuticals, Inc. Earnings
Ligand Pharmaceuticals, Inc. Earnings Report: Per Share Ligand Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Ligand Pharmaceuticals, Inc. Forecast Revenue Growth
Ligand Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Ligand Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $1.27 per share.
* Ligand Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.